Strata Critical Medical, Inc. (SRTA) Q3 2026 Earnings Call November 3, 2026 8:00 AM EST
Company Participants
Mathew Schneider – CFO of Clinical Services & VP of Finance and Investor Relations
William Heyburn – Co-CEO, CFO & Director
Melissa Tomkiel – Co- CEO, General Counsel, Corporate Secretary & Director
Conference Call Participants
William Bonello – Craig-Hallum Capital Group LLC, Research Division
Yuan Zhi – B. Riley Securities, Inc., Research Division
Jon Hickman – Ladenburg Thalmann & Co. Inc., Research Division
Benjamin Haynor – Lake Street Capital Markets, LLC, Research Division
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Strata Critical Medical Fiscal Third Quarter 2026 Earnings Release Conference Call. [Operator Instructions] As a reminder, this call is being recorded.
I would now like to turn the conference call over to Matt Schneider, CFO of Clinical Services and Vice President of Finance and Investor Relations. Matt, you may begin.
Mathew Schneider
CFO of Clinical Services & VP of Finance and Investor Relations
Thank you for standing by, and welcome to Strata’s conference call and webcast for the quarter ended September 30, 2026. We appreciate everyone joining us today. Before we get started, I would like to remind you of the company’s forward-looking statement and safe harbor language. Statements made in this conference call that are not historical facts, including statements about future time periods may be deemed to constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties, and actual future results may differ materially from those expressed or implied by the forward-looking statements.
We refer you to our SEC filings, including our annual report on Form 10-K and our quarterly report on Form 10-Q, each as filed with the SEC for a more detailed discussion of the risk
